A review on ZnO nanostructured materials: energy, environmental and biological applications

J Theerthagiri, S Salla, RA Senthil… - …, 2019 - iopscience.iop.org
Zinc oxide (ZnO) is an adaptable material that has distinctive properties, such as high-
sensitivity, large specific area, non-toxicity, good compatibility and a high isoelectric point …

[HTML][HTML] Peptide-drug conjugates and their targets in advanced cancer therapies

P Hoppenz, S Els-Heindl, AG Beck-Sickinger - Frontiers in chemistry, 2020 - frontiersin.org
Cancer became recently the leading cause of death in industrialized countries. Even though
standard treatments achieve significant effects in growth inhibition and tumor elimination …

Biomedical applications of zinc oxide nanomaterials

Y Zhang, TR Nayak, H Hong… - Current molecular …, 2013 - ingentaconnect.com
Nanotechnology has witnessed tremendous advancement over the last several decades.
Zinc oxide (ZnO), which can exhibit a wide variety of nanostructures, possesses unique …

A combined “eat me/don't eat me” strategy based on extracellular vesicles for anticancer nanomedicine

Z Belhadj, B He, H Deng, S Song, H Zhang… - Journal of …, 2020 - Taylor & Francis
ABSTRACT A long-term and huge challenge in nanomedicine is the substantial uptake and
rapid clearance mediated by the mononuclear phagocyte system (MPS), which enormously …

Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy

G Niu, X Chen - Current drug targets, 2010 - ingentaconnect.com
New blood vessel formation (angiogenesis) is fundamental to tumor growth, invasion, and
metastatic dissemination. The vascular endothelial growth factor (VEGF) signaling pathway …

[HTML][HTML] On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

EI Vrettos, G Mező, AG Tzakos - Beilstein journal of organic …, 2018 - beilstein-journals.org
Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …

Modification of kidney barrier function by the urokinase receptor

C Wei, CC Möller, MM Altintas, J Li, K Schwarz… - Nature medicine, 2008 - nature.com
Podocyte dysfunction, represented by foot process effacement and proteinuria, is often the
starting point for progressive kidney disease. Therapies aimed at the cellular level of the …

Nanoplatforms for targeted molecular imaging in living subjects

W Cai, X Chen - Small, 2007 - Wiley Online Library
Molecular or personalized medicine is the future of patient management and molecular
imaging plays a key role towards this goal. Recently, nanoplatform‐based molecular …

Multimodality molecular imaging of tumor angiogenesis

W Cai, X Chen - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
Molecular imaging is a key component of 21st-century cancer management. The vascular
endothelial growth factor (VEGF)/VEGF receptor signaling pathway and integrin α v β 3, a …

Integrin αvβ3‐targeted cancer therapy

Z Liu, F Wang, X Chen - Drug development research, 2008 - Wiley Online Library
Anti‐angiogenesis is a promising strategy for the treatment of cancer. Integrins, consisting of
two noncovalently bound transmembrane α and β subunits, are an important molecular …